Open AccessIndividualized home-monitoring of disease activity in adult patients with inflammatory bowel disease can be recommended in clinical practice: A randomized-clinical trial
Author(s) -
Dorit Vedel Ankersen,
Petra Weimers,
Dorte Marker,
Mette Bennedsen,
Sanaz Saboori,
Kristine Paridaens,
Johan Burisch,
Pia Munkholm
Publication year - 2019
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v25.i40.6158
Subject(s) - medicine , calprotectin , interquartile range , inflammatory bowel disease , randomized controlled trial , ehealth , psychological intervention , quality of life (healthcare) , disease , clinical trial , physical therapy , health care , nursing , psychiatry , economics , economic growth
The optimal way to home-monitor patients with inflammatory bowel disease (IBD) for disease progression or relapse remains to be found.